Bioscience Association Manitoba unveiled four winners, including Cerebra, to be honored on March 2 at its Annual Awards Dinner, an event recognizing the contributions of individuals and companies that have demonstrated exceptional leadership, innovation, and entrepreneurship in their field. 

“We are extremely proud of this year’s award winners and all they have accomplished,” says Kim Kline, president of Bioscience Association Manitoba, in a press release. “Their dedication, hard work, and commitment to excellence are a testament to the Manitoba advantage and the strength of our industry. We thank them for their contributions.”

This year’s four award winners, and descriptions as per Bioscience Association Manitoba, are:

Bioscience Company of the Year: Cerebra 

Cerebra is a leading medical device technology company transforming the future of sleep diagnosis and therapy. Cerebra’s technology enables researchers and clinicians to gain a true understanding of an individual’s sleep quality and reveals connections to physical, mental, and emotional health. 

By studying sleep where it happens, in the home, the innovation of odds ratio product combined with the most advanced in-home, self-applied polysomnography, they are transforming the diagnosis and treatment of major sleep disorders enabling a more personalized approach to sleep medicine. Cerebra unites innovators and researchers with the common goal and passion of putting “sleep” back into sleep medicine.

Most Outstanding Bioscience Student of the Year:  Daniel Gussakovsky, PhD 

Gussakovsky is a student in the department of chemistry at the University of Manitoba whose work will contribute significantly to the understanding of critical cellular pathways in breast/ovarian cancers and will potentially provide a novel therapeutic avenue. 

Outstanding Leadership in Bioscience of the Year: Albert (Bert) Friesen, PhD 

Friesen is the founder, CEO, and chair of the board at Medicure Inc. He has played a key role in founding several health industry companies, including serving as the first employee and then president of the Winnipeg Rh Institute, where he oversaw the development of the WinRho vaccine. 

Emerging Bioscience Company of the Year: Scimar

Scimar is a Manitoba-based biotech company focusing on preventing, detecting, and treating Type 2 diabetes. Scimar’s innovative solutions for diabetes are poised to make a significant impact in the fight against this prevalent disease.